Results 11 to 20 of about 4,080,452 (353)

An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity

open access: yesJournal of Immunology Research, 2018
Drug hypersensitivity may manifest ranging from milder skin reactions (e.g., maculopapular exanthema and urticaria) to severe systemic reactions, such as anaphylaxis, drug reactions with eosinophilia and systemic symptoms (DRESS)/drug-induced ...
Chun-Bing Chen   +6 more
doaj   +2 more sources

Variability of the Genes Involved in the Cellular Redox Status and Their Implication in Drug Hypersensitivity Reactions

open access: yesAntioxidants, 2021
Adverse drug reactions are a major cause of morbidity and mortality. Of the great diversity of drugs involved in hypersensitivity drug reactions, the most frequent are non-steroidal anti-inflammatory drugs followed by β-lactam antibiotics.
Pedro Ayuso   +2 more
doaj   +2 more sources

Desensitization for the prevention of drug hypersensitivity reactions. [PDF]

open access: yesKorean J Intern Med, 2022
Drug desensitization is the temporary induction of tolerance to a sensitized drug by administering slow increments of the drug, starting from a very small amount to a full therapeutic dose.
Kang SY, Seo J, Kang HR.
europepmc   +2 more sources

Flow‐based basophil activation test in immediate drug hypersensitivity. An EAACI task force position paper

open access: yesAllergy. European Journal of Allergy and Clinical Immunology, 2023
Diagnosing immediate drug hypersensitivity reactions (IDHRs) can pose a significant challenge and there is an urgent need for safe and reliable tests.
C. Mayorga   +11 more
semanticscholar   +1 more source

Biomarkers of immediate drug hypersensitivity

open access: yesAllergy. European Journal of Allergy and Clinical Immunology, 2023
Immediate drug hypersensitivity reactions (IDHRs) are a burden for patients and the health systems. This problem increases when taking into account that only a small proportion of patients initially labelled as allergic are finally confirmed after an ...
C. Mayorga   +5 more
semanticscholar   +1 more source

Viral infections and drug hypersensitivity

open access: yesAllergy. European Journal of Allergy and Clinical Immunology, 2022
Virus infections and T‐cell‐mediated drug hypersensitivity reactions (DHR) can influence each other. In most instances, systemic virus infections appear first.
W. Pichler, M. Brüggen
semanticscholar   +1 more source

An Updated Review of the Diagnostic Methods in Delayed Drug Hypersensitivity

open access: yesFrontiers in Pharmacology, 2021
Delayed drug hypersensitivity reactions are clinically diverse reactions that vary from isolated benign skin conditions that remit quickly with no or symptomatic treatment, drug discontinuation or even continued drug treatment, to the other extreme of ...
A. Copaescu   +4 more
semanticscholar   +1 more source

The important role of non‐covalent drug‐protein interactions in drug hypersensitivity reactions

open access: yesAllergy. European Journal of Allergy and Clinical Immunology, 2021
Drug hypersensitivity reactions (DHR) are heterogeneous and unusual immune reactions with rather unique clinical presentations. Accumulating evidence indicates that certain non‐covalent drug‐protein interactions are able to elicit exclusively effector ...
W. Pichler
semanticscholar   +1 more source

Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS)

open access: yesInternational Journal of Molecular Sciences, 2021
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS) is a severe type of adverse drug eruption associated with multiorgan involvement and the reactivation of human herpesvirus 6, which arises after ...
F. Miyagawa, H. Asada
semanticscholar   +1 more source

Comparison of methods for in-house screening of HLA*B57:01 to prevent abacavir hypersensitivity in HIV-1 care [PDF]

open access: yes, 2015
Abacavir is a nucleoside reverse transcriptase inhibitor used as part of combination antiretroviral therapy in HIV-1-infected patients. Because this drug can cause a hypersensitivity reaction that is correlated with the presence of the HLA-B*57:01 ...
Bonczkowski, Pawel   +18 more
core   +7 more sources

Home - About - Disclaimer - Privacy